In 2017, brand-name prescription drugs made up only 17% of total prescriptions filled but represented 79% of total drug spending, according to an updated study from the Blue Cross and Blue Shield Association.
Independent pharmacists in New York are calling for a state investigation into the practices of pharmacy benefit managers—the companies that negotiate drug prices on behalf of insurers and employers. They blame the PBMs for forcing owners to close up shop.
A Washington University researcher has pinpointed six biomarkers that could lead to a simple breathalyzer test for malaria.
Nearly a year ago, the private insurer in the state's overhauled Medicaid managed-care program slashed reimbursement rates to medical suppliers. Now a large provider is terminating its contract.
CommonWell members and Carequality participants will now have an easier time exchanging patient data, an example of vendor-driven interoperability.